Oh Young Bang/LinkedIn
Nov 9, 2025, 12:28
Oh Young Bang on Enhancement of Post-Stroke Neuroregeneration
Oh Young Bang, Professor of Neurology at Samsung Medical Center, CEO at S and E bio, shared on LinkedIn:
”We’re confirming safety in stroke patients first, then moving on to drug-loaded exosome treatments for neurodegeneration (PMID: 40883738).
The BBB-bypass approach would be key.”
Read the full article here.
Article: Engineered MSC-EVs loaded with BDNF-enhancing neuropeptides via a non-disruptive method enhance post-stroke neuroregeneration via intranasal delivery
Authors: Ji-Eun Kim, Ye Eun Ji, Hyeon Jun Hwang, Ga-Eun Go, Hyung-Jun Lim, Jaein Yoo, Jooho Kim, Doil Park, Eun Hee Kim, Doory Kim, Oh Young Bang
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 15, 2026, 15:20Sonal Sonu: Blood Donation Myths in Rural Areas
-
Apr 15, 2026, 15:01Augustina Isioma Ikusemoro: The Most Misunderstood Cause of a Prolonged APTT in the Laboratory
-
Apr 15, 2026, 14:55Donald Correll: Key Risk Factors for Venous Thromboembolism
-
Apr 15, 2026, 14:48Fadwa Said Abdelazim: Is Vaping Really ‘Safer’ for the Blood Than Smoking?
-
Apr 15, 2026, 14:42Augustina Isioma Ikusemoro: An Underrecognized Cause of Severe Thrombocytopenia Following Transfusion
-
Apr 15, 2026, 14:42Caitlin Raymond: Augmented Intelligence Enhancing Human Capability Without Replacement
-
Apr 15, 2026, 14:39Pooja Choradia: Recognizing Pulmonary Embolism in Pregnancy Before It Is Too Late
-
Apr 15, 2026, 14:38Alessandra Bosch։ Understanding Haemostasis in Children and Its Challenges
-
Apr 15, 2026, 14:29Joseph Caprini: The Future of VTE Care Is Shifting from Static Risk to Digital Twins